School of Medicine
Showing 1-100 of 220 Results
-
Neda Kaboodvand
Basic Life Res Scientist, Neurosurgery
Current Role at StanfordNeda Kaboodvand, PhD, is an Applied Research Scientist at Stanford University School of Medicine. Her research lies at the intersection of artificial intelligence, behavioral science, and clinical research, with a focus on using multimodal data to understand human behavior and improve clinical decision-making. She designs and leads experimental and observational studies and develops machine learning, statistical, and computational models to evaluate interventions, predict outcomes, and support personalized, adaptive approaches to care. A central part of her work involves modeling complex longitudinal and time-series data, including neural, electrophysiological, physiological, behavioral, imaging, and device-generated signals. By integrating these high-dimensional data sources, she develops models of patient and user state, identifies temporal patterns associated with outcomes and intervention response, and translates complex data into actionable insights for clinical and digital health systems.
-
Alexander D. Kaiser
Instructor, Cardiothoracic Surgery
BioAlexander Kaiser, PhD, is an applied mathematician and computational scientist who researches modeling and simulation of heart valves, focused on congenital heart valve disease and its surgical treatment. His recent research explores simulation-guided design of aortic valve repair of complex congenital heart defects. He has developed novel, nearly first-principles modeling methods for heart valves called elasticity-based design. These methods produce robust and realistic flows in fluid-structure interaction simulations. Dr. Kaiser is an Instructor in Cardiothoracic Surgery at Stanford University working with Michael Ma and Alison Marsden. He completed his PhD in Mathematics with Charles Peskin at the Courant Institute of Mathematical Sciences at New York University, where he was awarded the Kurt O. Friedrichs Prize for Outstanding Dissertation in Mathematics.
-
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordParaphrasing the mathematician Alexander Grothendieck: the essential thing is to pose problems in the right framework.
Sharada is developing a new field, Mathematical Medicine, which applies pure mathematical frameworks to genomic and multi-omic data for quantitative, personalized diagnosis. Her work addresses a fundamental challenge in contemporary medicine: prevailing cohort-based diagnostic approaches are not always equipped to capture the biological mechanisms relevant to individual patients, particularly in long-pending, complex “outlier” cases.
After more than a decade of research and close collaboration with biochemists at the Stanford Genome Technology Center (Dept. of Biochemistry), Sharada concluded that the mathematics currently used for multi-omic diagnosis is not sufficient for the level of biological and clinical complexity being attempted, particularly for individual patients who lack relevant statistical cohorts. Her conclusion echoes the perspective of the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.” This gap has important clinical consequences: individual biological differences may be treated as “noise” or as "outliers" rather than as clinically meaningful information. As a result, many patients with complex or multi-system conditions remain undiagnosed or incorrectly diagnosed, sometimes for decades, delaying effective treatment and, in some cases, allowing disease processes to worsen.
Mathematical Medicine addresses these limitations by developing an intermediate translational layer between cohort-based statistical models and individualized multi-omic diagnosis and clinical decision-making. The approach reflects the data-first philosophy articulated by the late mathematician Jim Simons: “We don’t start with models. We start with data. We don’t have any preconceived notions.” By developing new mathematical frameworks for interpreting an individual’s genomic and multi-omic data, Mathematical Medicine seeks to seeks to let the data speak for itself while enabling quantitative, individualized diagnosis and clinical decision-making.
Sharada’s research has led to the diagnosis and identification of appropriate treatment pathways for patients with previously undiagnosed, complex conditions. These rare and atypical cases also reveal biological relationships not apparent in population-level analyses, leading to insights that can inform broader research, clinical applications, and drug development.
Further information on this field, including opportunities for early philanthropic partnerships, is available at: https://mathmed-2026.web.app -
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Neil Kamdar
Assistant Director of Analytics, Center for Population Health Sciences
Biostatistician 3, Center for Population Health SciencesBioI am a health services researcher and applied methodologist focused on clinical and policy applications in disabilities research, women's health, general surgery, and mental health analyses. My focus has been on leveraging Medicare, private payer claims (Health Care Cost Institute (HCCI), MarketScan, OptumInsight, etc.) and Medicaid to understand cost, utilization, and outcomes. This work has been foundational in the development of large-scale studies on vulnerable populations that have typically been under-served or insufficiently studies in the health services research domain.
I serve as the Assistant Director of Analytics at the Center for Population Health Sciences at Stanford, focused on the development of the American Family Cohort (AFC) data, a primary care registry that provides substantial insights into clinical outcomes, utilization, and a particular focus on COVID-19 and Long COVID outcome analyses. Ancillary work would involve the development of research collaborations throughout Stanford Medicine with the interest in creating scholarship across the many domains of the Center for Population Health Sciences.
In addition to this role at Stanford, I also maintain an appointment at the University of Michigan, Institute for Healthcare Policy and Innovation, where I serve as an analytic lead in the development of administrative claims and electronic medical records analyses leading to publications in general and subject-specific journals.
I have been successful in being funded as a co-investigator with several federal and foundation agencies, including the National Institutes of Health (NIH), Department of Defense (DOD), Agency for Healthcare Research and Quality (AHRQ), Neilsen Foundation focused on traumatic spinal cord injury, among many others. I have also provided foundational analyses in the development of Clinical Quality Initiatives (CQIs), which are state-wide initiatives aimed at improving the health and efficiency of hospitals and institutions, with a focus on maternal and fetal medicine in the State of Michigan. -
Devanish Narasimhasanth Kamtam
Visiting Instructor, Cardiothoracic Surgery - Thoracic Surgery
BioDr. Devanish Kamtam is a Visiting Instructor in the Division of Thoracic Surgery at Stanford University, working in Dr. Joseph Shrager's lab. His research focuses on surgical AI, AI in medical imaging, and clinical outcomes in Thoracic Surgery. He completed his MBBS at Gandhi Medical College, Hyderabad and MS in General Surgery at AIIMS New Delhi.
-
Jennifer Kang
Academic Prog Prof 2, Pediatrics - Infectious Diseases
Current Role at StanfordProgram Manager, Global Child Health Program
-
Max Kasun
Research Professional, Psychiatry and Behavioral Sciences
BioMax Kasun works in the Roberts Ethics Lab and Kim Ethics Lab at Stanford, which use empirical methods to help anticipate, clarify and resolve ethical issues in modern biomedical research. He has interests in empirical and normative thought dedicated to increasing scientific understanding and societal appreciation of the nature, internal experience, and prevalence of mental illness and well-being, as well as in moral philosophy (e.g. justice, action, capability, neo-Aristotelianism, and pragmatism), cognitive and affective sciences, and philosophy of mind (e.g. embodiment and personhood). He has co-authored scientific, peer-reviewed articles and other scholarly work investigating ethical issues in research (e.g. authentic voluntarism in informed consent), medical education, public health, and neuroscience. His most recent contributions to NIH-funded scientific work (National Center for Advancing Translational Sciences; PI: Dr. Jane Kim) have focused on investigating ethical issues encountered in the design, development, and clinical integration of artificial intelligence, e.g., how environmental and cognitive factors shape appraisals of AI tools, clinical judgments, trust, and health decision-making.
Max is a co-author of several chapters in APA's Study Guide to DSM-5-TR (2024) including the chapters on bipolar and related disorders and personality disorders (American Psychiatric Association). He has published work in and provided editorial support for the peer-reviewed journal Academic Medicine (Oxford University Press) and for two works on the subject of trauma and crisis and related interventions, including a reference guide for providing mental health care to victims of state atrocity (United Nations, Springer). Previously, he served on leadership teams for the Stanford Mental Health Technology and Innovation Hub and Neurodiversity Project.
Max is currently working to develop a new Special Initiative of the Chair on Mental Health Care for Unhoused and Justice-Involved Persons (see https://med.stanford.edu/psychiatry/special-initiatives/mhuj.html). The initiative aims to bring together a community of scholars, public stakeholders, and health care professionals to help advance more humane and participatory inquiry and health policy in service of a population that faces profound controversy, health stigma, and scientific neglect. The initiative aims to improve how science is communicated to the public and policy decision-makers and to develop more evidence-based, pragmatic, strengths-based, and trauma-informed approaches to mental health care for unhoused persons, including those who have experienced episodic or cyclical involvement in the criminal and civil justice systems. -
Ankita Kaulberg
Director of Innovation & Technology, Epidemiology and Population Health
Current Role at StanfordDirector of Innovation & Technology, HEARTS Lab
Stanford School of Medicine -
Dr Mohit Kaushal MD
Adjunct Professor, Biomedical Data Science
BioDr. Mohit Kaushal is an accomplished entrepreneur, investor, and physician with a distinguished career spanning clinical medicine, academia, public policy and industry. He has served as an investor and board member for numerous public and private transformative companies, including Oak Street Health (NYSE: OSH, acquired by CVS Health, NYSE: CVS), Humedica (acquired by Optum, NYSE: UNH), RxAnte (acquired by Millennium), Change Healthcare (acquired by Emdeon), Universal American (NYSE: UAM, acquired by WellCare, NYSE: WCG), goBalto (acquired by Oracle, NYSE: ORCL), CitiusTech (acquired by Baring), Wellframe (acquired by HealthEdge), and George Clinical (acquired by Hillhouse).
During the Obama administration, Dr. Kaushal served on the White House Health IT Task Force, contributing to the implementation of the Affordable Care Act’s technology initiatives and testifying before Congress on the role of technology and payment reform in Medicare. He also established and led the first dedicated healthcare team at the Federal Communications Commission, where his work included partnering with the FDA to streamline regulation of converged telecommunications, analytics, and medical devices, ultimately resulting in the FDA’s mobile medical applications guidance. His team also restructured the Rural Healthcare Fund into the Healthcare Connect Fund, aligning its resources with broader healthcare technology and payment reforms.
In academia, Dr. Kaushal is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University, which integrates AI, biomedical informatics, biostatistics and computer science to advance precision health. His teaching emphasizes the application of data—ranging from molecular and tissue-level information to imaging, EHR, biosensors, and population health—to improve medical outcomes.
He remains active in public policy as a Scholar in Residence at the Duke-Margolis Center for Health Policy and was previously a Visiting Scholar at the Brookings Institution. His policy work includes previous appointments to the FDASIA Workgroup of the Health IT Policy Committee and the National Committee on Vital and Health Statistics, advising HHS on data access and use.
Dr. Kaushal is an emergency physician by training, holds an MBA from Stanford University, and earned his MD with distinction from Imperial College London. -
Micah Kelly
Radiation and Cancer Biology Administrative Programs Lead, Radiation Oncology - Radiation Biology
Current Role at StanfordAdministrative Associate to Drs. Erinn Rankin, Ted Graves, and Laura Attardi.
-
Samantha M Kerath
Director of Finance and Administration, Microbiology and Immunology
Current Role at StanfordDirector of Finance & Administration
Microbiology & Immunology and Baxter Lab -
Harold Keyserling
Clinical Associate Professor (Affiliated), Rad/Veterans Affairs
Neuroradiologist, Radiology - Diagnostic RadiologyBioHarold Keyserling, MD is a diagnostic radiologist with subspecialty certification in neuroradiology. In addition to his clinical work, Dr. Keyserling is actively engaged in resident education and is a consulting radiologist for the Centers for Disease Control and Prevention (CDC), Division of Global Migration Health.
-
Steve Khachi, M.D.
Adjunct Lecturer, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Steve Khachi is a double board-certified child, adolescent, and adult psychiatrist. He is the Founder, CEO, and Medical Director of Mind Study Center (est. 2017) and Mind Pulse Center (est. 2024) in Pasadena, California. Mind Study Center is an integrated outpatient clinic offering psychiatric evaluation, medication management, psychotherapy, neuropsychological evaluation, and transcranial magnetic stimulation (TMS); Mind Pulse Center is an insurance-based clinic specializing in TMS and medication management for treatment-resistant depression.
He serves as Adjunct Lecturer in the Division of Child and Adolescent Psychiatry and Child Development at Stanford University School of Medicine, where he has trained child and adolescent psychiatry fellows in transcranial magnetic stimulation and lectures on developmental psychopathology, psychopharmacology, psychotherapy, and neuroscience, and as Adjunct Clinical Assistant Professor at the Keck School of Medicine of USC, where he supervises child and adolescent psychiatry fellows. His interests include neuromodulation and TMS, precision and measurement-based psychiatry, and the translation of neuroscience into outpatient care.
His research training spans cellular and systems neuroscience, including studies of bipolar disorder using patient-derived induced pluripotent stem cells at UC San Diego and the Salk Institute (with John Kelsoe, M.D., and Fred Gage, Ph.D.), two-photon microscopy and electrophysiology as an HHMI-NIH Research Scholar, and cerebrovascular research at UCSF.
CLINICAL FOCUS: Child and Adolescent Psychiatry; Adult Psychiatry; TMS and Neuromodulation; Treatment-Resistant Depression; Mood Disorders; ADHD; Anxiety Disorders; Precision and Measurement-Based Psychiatry.
TRAINING AND CERTIFICATION: Board Certified, American Board of Psychiatry and Neurology, Child and Adolescent Psychiatry (2016) and Psychiatry (2015). Fellowship, Child and Adolescent Psychiatry, Stanford University (2016), Chief Fellow 2015-2016. Residency, General Psychiatry, UC San Diego (2014). M.D., University of Wisconsin School of Medicine and Public Health (2011). HHMI-NIH Research Scholar, National Institutes of Health (2008-2009). B.S., Biochemistry-Molecular Biology, UC Santa Barbara (2004).
HONORS: Top Doctors, Pasadena Magazine (2018, 2019); Chief Fellow, Stanford University (2015-2016); Trainee Advisory Board, Acta Psychiatrica Scandinavica (2012-2015); PRITE Scholar Award, UC San Diego (2012); Advanced HHMI-NIH Research Scholar Fellowship (2009); Excellence in Research and Scholarly Activity Award, Des Moines University (2007).
SELECTED PUBLICATIONS: Chang K, Hall R, Khachi S, Howe M, Singh M. Bipolar and Mood Disorders in Adolescents. In: Treating Adolescents, 2nd ed. 2014:223-51. | Khachi S, Gubbels SP, Robinson RA, Hansen MR. Ganglion Cyst Presenting as an External Auditory Canal Mass. Otolaryngol Head Neck Surg. 2011;144(1):131-2. | Zhu W, Khachi S, et al. Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int. 2008;52:1086-91. | Khachi S, Zhu Y, Yang GY. Preparation and analysis of endothelial progenitor cells associated with angiogenesis. Methods Mol Biol. 2010;621:139-48.
PROFESSIONAL MEMBERSHIPS: American Academy of Child & Adolescent Psychiatry; American Psychiatric Association; American Medical Association.
WEB: mindstudycenter.com | mindpulsecenter.com -
Amy Khokhar
Temporary Employee, Medicine - Med/Stanford Prevention Research Center
Casual - Non-Exempt, Stanford Center on LongevityCurrent Role at StanfordStanford Lifestyle Medicine Program Administrator
-
Michaela Kiernan
Senior Research Scholar, Medicine - Med/Stanford Prevention Research Center
Current Research and Scholarly InterestsResearch interests include the design and experimental testing of innovative strategies to improve recruitment and retention of randomized clinical trials.
-
Cindy Kim
Clinical Rsch Coord 2, Adult Neurology
BioHello, Thank you for connecting with me through my profile. I developed a passion for health and wellness early in life which led me to pursue a B.S. in Health Education with an emphasis in Community Health. My direct patient care experience further solidified my dedication to improving patient outcomes and deepened my understanding of the healthcare system. Driven by my desire to expand my impact, I transitioned into my current role as Clinical Research Coordinator Associate at the Stanford Stroke Center, focusing on advancing the ability to predict stroke risks and improve patient health through the lens of research.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am a physician with specialized training in gastroenterology and hepatology. My research primarily focuses on clinical research into metabolic dysfunction-associated steatotic liver disease (MASLD), chronic liver diseases, and obesity-related gastrointestinal diseases, with a population-based study. In addition, my research has expanded to encompass cardiology, endocrinology, neurology, and psychiatry. I have extensive experience in large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 300 published papers in prominent journals, including Gastroenterology, Journal of Hepatology, Gut, Hepatology, and Clinical Gastroenterology and Hepatology, with the author serving as first or corresponding author. These publications have been cited more than 22000 times with an H-index of 73.
-
Edwin Kim
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Edwin Kim, MD FAPA is an expert and leader in addiction treatment and physician health, who is board-certified in Psychiatry, Addiction Medicine, and Addiction Psychiatry. Dr. Kim is the Director of Addiction Treatment Services at the Veterans Affairs Palo Alto Healthcare System, and a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine. At the VA Palo Alto, Dr. Kim teaches and supervises medical students, residents and fellows. He is also the President-Elect of the Federation of State Physician Health Programs, and a Councilor-at-Large of the Northern California Psychiatric Society. He currently serves as a Medical Director at the Foundation of the Pennsylvania Medical Society’s Physicians’ Health Program and Nurses’ Health Program.
-
Jeewon Sylvia Kim
Program Manager, SPARK at Stanford
Current Role at StanfordProgram manager for SPARK Translational Science Program overseeing educational seminar series, managing projects and facilitating SPARK global operations.
-
Johanna Kim
Executive Director, AIMI, Rad/Integrative Biomedical Imaging Informatics at Stanford
BioJohanna specializes in launching and leading world-class research programs. At Stanford AIMI, she plays a pivotal role in the development and design of all programs, particularly focusing on research and education programs, funding opportunities, and major events. Her leadership extends to shaping partnership programs, fundraising, and enhancing AIMI's outreach strategies. Skilled in building strong teams and fostering interdisciplinary collaborations, Johanna adeptly navigates the complexities of the academic and healthcare sectors. Her strategic support has been invaluable in advancing technology development, securing substantial research funding, and elevating the impact of publications. Johanna’s 20-year career is marked by her commitment to transforming healthcare through innovative technology.
-
Kaitlyn Kim
Stanford Student Employee, Health Policy
BioI am driven to build a dynamic career at the intersection of science, medicine, industry, and policy, with a focus on translational medicine and systems-level leadership. My goal is to help bridge the gap between research and real-world application, accelerating the thoughtful development of innovative therapies and expanding accessibility to quality care.
